334 related articles for article (PubMed ID: 22104196)
1. Current status of the congenital myasthenic syndromes.
Engel AG
Neuromuscul Disord; 2012 Feb; 22(2):99-111. PubMed ID: 22104196
[TBL] [Abstract][Full Text] [Related]
2. Congenital myasthenic syndromes in 2012.
Engel AG
Curr Neurol Neurosci Rep; 2012 Feb; 12(1):92-101. PubMed ID: 21997714
[TBL] [Abstract][Full Text] [Related]
3. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
Andreux F; Hantaï D; Eymard B
Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
[TBL] [Abstract][Full Text] [Related]
4. Congenital myasthenic syndromes: A diverse array of molecular targets.
Engel AG; Ohno K; Sine SM
J Neurocytol; 2003; 32(5-8):1017-37. PubMed ID: 15034283
[TBL] [Abstract][Full Text] [Related]
5. [Congenital myasthenic syndromes].
Ohno K
Rinsho Shinkeigaku; 2012; 52(11):1159-61. PubMed ID: 23196549
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of congenital myasthenic syndromes.
Engel AG; Ohno K; Sine SM
Mol Neurobiol; 2002; 26(2-3):347-67. PubMed ID: 12428764
[TBL] [Abstract][Full Text] [Related]
7. [Genetic defects and disorders at the neuromuscular junction].
Ohno K
Brain Nerve; 2011 Jul; 63(7):669-78. PubMed ID: 21747136
[TBL] [Abstract][Full Text] [Related]
8. Current understanding of congenital myasthenic syndromes.
Engel AG; Sine SM
Curr Opin Pharmacol; 2005 Jun; 5(3):308-21. PubMed ID: 15907919
[TBL] [Abstract][Full Text] [Related]
9. Congenital myasthenic syndromes: multiple molecular targets at the neuromuscular junction.
Engel AG; Ohno K; Shen XM; Sine SM
Ann N Y Acad Sci; 2003 Sep; 998():138-60. PubMed ID: 14592871
[TBL] [Abstract][Full Text] [Related]
10. Congenital myasthenic syndromes and the formation of the neuromuscular junction.
Beeson D; Webster R; Cossins J; Lashley D; Spearman H; Maxwell S; Slater CR; Newsom-Davis J; Palace J; Vincent A
Ann N Y Acad Sci; 2008; 1132():99-103. PubMed ID: 18567858
[TBL] [Abstract][Full Text] [Related]
11. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.
Engel AG; Shen XM; Selcen D; Sine SM
Lancet Neurol; 2015 Apr; 14(4):420-34. PubMed ID: 25792100
[TBL] [Abstract][Full Text] [Related]
12. Further observations in congenital myasthenic syndromes.
Engel AG; Shen XM; Selcen D; Sine SM
Ann N Y Acad Sci; 2008; 1132():104-13. PubMed ID: 18567859
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation.
Yasaki E; Prioleau C; Barbier J; Richard P; Andreux F; Leroy JP; Dartevelle P; Koenig J; Molgó J; Fardeau M; Eymard B; Hantaï D
Neuromuscul Disord; 2004 Jan; 14(1):24-32. PubMed ID: 14659409
[TBL] [Abstract][Full Text] [Related]
14. Congenital myasthenic syndrome: a brief review.
Lorenzoni PJ; Scola RH; Kay CS; Werneck LC
Pediatr Neurol; 2012 Mar; 46(3):141-8. PubMed ID: 22353287
[TBL] [Abstract][Full Text] [Related]
15. Genetic basis and phenotypic features of congenital myasthenic syndromes.
Engel AG
Handb Clin Neurol; 2018; 148():565-589. PubMed ID: 29478601
[TBL] [Abstract][Full Text] [Related]
16. Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.
Maselli RA; Arredondo J; Cagney O; Ng JJ; Anderson JA; Williams C; Gerke BJ; Soliven B; Wollmann RL
Hum Mol Genet; 2010 Jun; 19(12):2370-9. PubMed ID: 20371544
[TBL] [Abstract][Full Text] [Related]
17. New horizons for congenital myasthenic syndromes.
Engel AG; Shen XM; Selcen D; Sine S
Ann N Y Acad Sci; 2012 Dec; 1275(1):54-62. PubMed ID: 23278578
[TBL] [Abstract][Full Text] [Related]
18. Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis.
Ohno K; Ito M; Kawakami Y; Krejci E; Engel AG
Chem Biol Interact; 2013 Mar; 203(1):335-40. PubMed ID: 22981737
[TBL] [Abstract][Full Text] [Related]
19. Congenital myasthenic syndromes: genetic defects of the neuromuscular junction.
Ohno K; Engel AG
Curr Neurol Neurosci Rep; 2002 Jan; 2(1):78-88. PubMed ID: 11898587
[TBL] [Abstract][Full Text] [Related]
20. LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin.
Maselli RA; Fernandez JM; Arredondo J; Navarro C; Ngo M; Beeson D; Cagney O; Williams DC; Wollmann RL; Yarov-Yarovoy V; Ferns MJ
Hum Genet; 2012 Jul; 131(7):1123-35. PubMed ID: 22205389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
